SkyePharma in deal with Dr Reddy's on delivery systems

UK-based SkyePharma says it has entered into an agreement with Indian drug major Dr Reddy's Laboratories to undertake a feasibility study. The costs of this study, of a product utilizing two of SkyePharma's proprietary drug delivery systems, will be paid for by Dr Reddy's. The product in question was not identified.

The UK firm will also receive a small upfront payment. If the feasibility study is successful, full development activities will begin later this year.

SkyePharma's chief executive, Frank Condella, said: "we are very pleased to enter into this collaboration with Dr Reddy's on a new product development opportunity and hope to extend the collaboration to other products."